Karaboyas A, Zhao J, Ma J, Moore C, et al. Incorporation of Calcimimetics into End-Stage Kidney Disease Bundle: Changes in Etelcalcetide Utilization and Parathyroid Hormone Control following End of Transitional Drug Add-On Payment Adjustment Designation. Clin J Am Soc Nephrol 2025;20:218-228.
PMID: 39378354